AJG Quote, Financials, Valuation and Earnings

CorVel has a net margin of 18.9% compared to Arthur J. Gallagher &'s net margin of 11.41%. Arthur J. Gallagher &'s return on equity of 10.03% beat CorVel's return on equity of 33.58%.

Arthur J. Gallagher & has a consensus price target of $336.95, signalling upside risk potential of 9.38%. On the other hand CorVel has an analysts' consensus of -- which suggests that it could fall by --. Given that Arthur J. Gallagher & has higher upside potential than CorVel, analysts believe Arthur J. Gallagher & is more attractive than CorVel.

Arthur J. Gallagher & has a beta of 0.708, which suggesting that the stock is 29.209% less volatile than S&P 500. In comparison CorVel has a beta of 0.978, suggesting its less volatile than the S&P 500 by 2.168%.

Arthur J. Gallagher & has a quarterly dividend of $0.65 per share corresponding to a yield of 0.81%. CorVel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Arthur J. Gallagher & pays 35.92% of its earnings as a dividend. CorVel pays out -- of its earnings as a dividend. Arthur J. Gallagher &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Arthur J. Gallagher & quarterly revenues are $3.7B, which are larger than CorVel quarterly revenues of $231.5M. Arthur J. Gallagher &'s net income of $704.4M is higher than CorVel's net income of $26.4M. Notably, Arthur J. Gallagher &'s price-to-earnings ratio is 47.39x while CorVel's PE ratio is 52.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arthur J. Gallagher & is 6.00x versus 5.57x for CorVel. Usually stocks with elevated PS ratios are considered overvalued.

eHealth has a net margin of 18.9% compared to Arthur J. Gallagher &'s net margin of 1.72%. Arthur J. Gallagher &'s return on equity of 10.03% beat eHealth's return on equity of 4.17%.

Arthur J. Gallagher & has a consensus price target of $336.95, signalling upside risk potential of 9.38%. On the other hand eHealth has an analysts' consensus of $10.00 which suggests that it could grow by 167.38%. Given that eHealth has higher upside potential than Arthur J. Gallagher &, analysts believe eHealth is more attractive than Arthur J. Gallagher &.

Arthur J. Gallagher & has a beta of 0.708, which suggesting that the stock is 29.209% less volatile than S&P 500. In comparison eHealth has a beta of 0.969, suggesting its less volatile than the S&P 500 by 3.055%.

Arthur J. Gallagher & has a quarterly dividend of $0.65 per share corresponding to a yield of 0.81%. eHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Arthur J. Gallagher & pays 35.92% of its earnings as a dividend. eHealth pays out 55.3% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Arthur J. Gallagher & quarterly revenues are $3.7B, which are larger than eHealth quarterly revenues of $113.1M. Arthur J. Gallagher &'s net income of $704.4M is higher than eHealth's net income of $2M. Notably, Arthur J. Gallagher &'s price-to-earnings ratio is 47.39x while eHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arthur J. Gallagher & is 6.00x versus 0.20x for eHealth. Usually stocks with elevated PS ratios are considered overvalued.

Kingstone Companies has a net margin of 18.9% compared to Arthur J. Gallagher &'s net margin of 7.69%. Arthur J. Gallagher &'s return on equity of 10.03% beat Kingstone Companies's return on equity of 36.5%.

Arthur J. Gallagher & has a consensus price target of $336.95, signalling upside risk potential of 9.38%. On the other hand Kingstone Companies has an analysts' consensus of $22.00 which suggests that it could grow by 52.88%. Given that Kingstone Companies has higher upside potential than Arthur J. Gallagher &, analysts believe Kingstone Companies is more attractive than Arthur J. Gallagher &.

Arthur J. Gallagher & has a beta of 0.708, which suggesting that the stock is 29.209% less volatile than S&P 500. In comparison Kingstone Companies has a beta of 0.571, suggesting its less volatile than the S&P 500 by 42.923%.

Arthur J. Gallagher & has a quarterly dividend of $0.65 per share corresponding to a yield of 0.81%. Kingstone Companies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Arthur J. Gallagher & pays 35.92% of its earnings as a dividend. Kingstone Companies pays out -- of its earnings as a dividend. Arthur J. Gallagher &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Arthur J. Gallagher & quarterly revenues are $3.7B, which are larger than Kingstone Companies quarterly revenues of $50.5M. Arthur J. Gallagher &'s net income of $704.4M is higher than Kingstone Companies's net income of $3.9M. Notably, Arthur J. Gallagher &'s price-to-earnings ratio is 47.39x while Kingstone Companies's PE ratio is 9.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arthur J. Gallagher & is 6.00x versus 1.10x for Kingstone Companies. Usually stocks with elevated PS ratios are considered overvalued.

Marsh & McLennan Companies has a net margin of 18.9% compared to Arthur J. Gallagher &'s net margin of 19.56%. Arthur J. Gallagher &'s return on equity of 10.03% beat Marsh & McLennan Companies's return on equity of 29.77%.

Arthur J. Gallagher & has a consensus price target of $336.95, signalling upside risk potential of 9.38%. On the other hand Marsh & McLennan Companies has an analysts' consensus of $231.12 which suggests that it could grow by 9.59%. Given that Marsh & McLennan Companies has higher upside potential than Arthur J. Gallagher &, analysts believe Marsh & McLennan Companies is more attractive than Arthur J. Gallagher &.

Arthur J. Gallagher & has a beta of 0.708, which suggesting that the stock is 29.209% less volatile than S&P 500. In comparison Marsh & McLennan Companies has a beta of 0.796, suggesting its less volatile than the S&P 500 by 20.374%.

Arthur J. Gallagher & has a quarterly dividend of $0.65 per share corresponding to a yield of 0.81%. Marsh & McLennan Companies offers a yield of 1.55% to investors and pays a quarterly dividend of $0.82 per share. Arthur J. Gallagher & pays 35.92% of its earnings as a dividend. Marsh & McLennan Companies pays out 37.27% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Arthur J. Gallagher & quarterly revenues are $3.7B, which are smaller than Marsh & McLennan Companies quarterly revenues of $7.1B. Arthur J. Gallagher &'s net income of $704.4M is lower than Marsh & McLennan Companies's net income of $1.4B. Notably, Arthur J. Gallagher &'s price-to-earnings ratio is 47.39x while Marsh & McLennan Companies's PE ratio is 25.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arthur J. Gallagher & is 6.00x versus 4.17x for Marsh & McLennan Companies. Usually stocks with elevated PS ratios are considered overvalued.